3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Inflammation
1
Carcinoma, Hepatocellular
1
Interventions
Ibuprofen
2
palbociclib
1
Weights and Measures
1
Rivaroxaban
1
Resistance Training
1
Qigong
1
Nutrition Assessment
1
Methods
1
Massage
1
Ketorolac
1
Hyperspectral Imaging
1
High-Intensity Interval Training
1
Fish Oils
1
Eating
1
Diet Records
1
Dexmedetomidine
1
Chromatin Immunoprecipitation Sequencing
1
CHR 2845
1
Body Height
1
Blood Specimen Collection
1
Basal Metabolism
1
Aspirin
1
Anti-Inflammatory Agents, Non-Steroidal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Inflammation
×
CHR 2845
×
Clear all
NCT02759601
2018-12-20
CHR-2845
Queen Mary University of London
Phase 1/2
Unknown
69 enrolled